Fundz

Asymchem Acquires Snapdragon Chemistry

PRIVATEFeb 11, 2022

Acquiring Company

Asymchem

Acquired Company

Snapdragon Chemistry

ManufacturingBiotechnologyScience And EngineeringPharmaceuticalManufacturingInformation TechnologyHardware

Description

Asymchem Laboratories (Tianjin) Co., Ltd. (stock code: 002821.SZ/6821.HK) ("Asymchem"), a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a seamless path from preclinical process R&D through commercial cGMP manufacture.

Quick answer

Asymchem is acquiring Snapdragon Chemistry, announced February 11, 2022.

How much did Asymchem pay for Snapdragon Chemistry?
The deal value was not disclosed.
What does Asymchem do?
Asymchem is a leading global manufacturer of pharmaceutical ingredients and a trusted partner to pharmaceutical and biotechnology companies worldwide.
Who are the decision-makers at Asymchem?
Fundz holds 1 contact at Asymchem. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Science And Engineering and Pharmaceutical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Asymchem, and when

When Asymchem changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Asymchem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Asymchem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Asymchem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Asymchem

About

Asymchem is a leading global manufacturer of pharmaceutical ingredients and a trusted partner to pharmaceutical and biotechnology companies worldwide. With a robust track record and a deep commitment to quality and innovation, Asymchem offers a comprehensive range of services, including custom synthesis, process development, and manufacturing of small molecules, peptides, oligonucleotides, and biologics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Asymchem makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Franck
Likely contact at this company
••••••••@••••••••

See Franck's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Asymchem's next move

Learn about Strategic plan

Frequently asked

Who acquired Snapdragon Chemistry?

Snapdragon Chemistry was acquired by Asymchem. The deal was reported on February 11, 2022. Asymchem is a leading global manufacturer of pharmaceutical ingredients and a trusted partner to pharmaceutical and biotechnology companies worldwide. Asymchem is privately held and operates in Manufacturing.

When did Asymchem acquire Snapdragon Chemistry?

Asymchem's acquisition of Snapdragon Chemistry was reported on February 11, 2022. Asymchem Laboratories (Tianjin) Co., Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Snapdragon Chemistry do?

Founded in 2014 out of MIT and Boston University, Snapdragon Chemistry designs practical manufacturing solutions for challenging chemical processes. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.